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Abstract
Background. Nontuberculous mycobacteria (NTM) are an important cause of morbidity and
mortality in the U.S., yet not much is known about the prevalence and risk factors. It is thought to
be increasing and most commonly found in women and older adults. The objectives of this project
were to estimate the burden of NTM in Nebraska and to describe the patterns of NTM infection
including location, species, specimen source, and patient demographic characteristics.
Methods. The National Electronic Disease Surveillance System was searched for all NTM infections
reported from 2012-2017. Cases were classified as either pulmonary or nonpulmonary and
available information was assessed including age, gender, and species type.
Results. 759 cases of NTM infection in Nebraska were identified over the six-year period. The
annualized isolation rate was 6.16 cases per 100,000 population. The overall isolation rate
decreased over the study period, however, there was an increase in nonpulmonary isolates.
Nonpulmonary cases predominated (54%) and Mycobacterium Avium Intracellulare was the most
common species identified.
Conclusions. Nonpulmonary NTM may be a more important cause of disease than previously
recognized. The differing trends in pulmonary and nonpulmonary NTM isolation indicate a
difference in disease and associated risk factors. Further efforts to monitor disease trends and
differences in risk factors should be undertaken.
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Introduction
Nontuberculous mycobacteria (NTM) cause illness most frequently in the form of lung
disease, but can also infect other areas of the body including skin and soft tissue, bones, joints, and
lymph nodes. Recently nontuberculous mycobacteria have been identified as an important cause of
healthcare associated infections. Over 140 NTM species have been identified and include all
mycobacteria other than Mycobacterium tuberculosis and Mycobacterium leprae. They are
traditionally classified by their rate of growth, either rapid or slow growers (Griffith, 2017; Li,
Abebe, Cronk, & Bartram, 2017). These mycobacteria are free-living organisms found in the
environment, and have been recovered from tap water, surface water, soil, animals, and food
products (Baker et al., 2017; Griffith et al., 2007; Griffith, 2017). Biofilms that often form in water
systems provide a suitable, nutrient rich-environment for mycobacteria (Griffith et al., 2007; Li et
al., 2017). Commonly found in household and hospital plumbing such as water taps and shower
heads, these opportunistic pathogens can also be readily aerosolized (Baker et al., 2015; Falkinham,
2016).
Although these organisms can inhabit body secretions or surfaces without causing disease,
there are four distinct manifestations of clinical illness caused by NTM. These clinical syndromes
include progressive pulmonary disease, superficial lymphadenitis, disseminated disease in
immunocompromised persons, and skin and soft tissue infection (Cassidy, Hedberg, Saulson,
McNelly, & Winthrop, 2009; Griffith, 2017). Chronic pulmonary disease has been documented as
the most common clinical presence of NTM (Griffith et al., 2007). The incubation period for NTM
disease varies, but on average, NTM disease presents symptoms less than four weeks after
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exposure, however, it can be indolent for as long as nine months (Li et al., 2017). Symptoms are
dependent upon the site of infection and present in a variety of ways (Bancroft et al., 2017).
Epidemiology of NTM
The burden of disease due to NTM in the United States is unknown, however, experts
believe that it is increasing (Cassidy et al., 2009; Griffith, 2017; Griffith et al., 2007; Henkle,
Hedberg, Schafer, Novosad, & Winthrop, 2015; Prevots & Marras, 2015). As the prevalence is
increasing, it is suggested that mortality due to nontuberculous mycobacterial disease will also
increase (Mirsaeidi, Machado, Garcia, & Schraufnagel, 2014). Annual rates of pulmonary NTM
disease in North America are estimated to range from 5 to 10 per 100,000 persons, but this varies
by geographic region (Prevots & Marras, 2015; Prevots et al., 2010). Population-based data to
confirm this are limited due to the lack of a mandate for reporting of laboratory isolation of, or
disease due to, nontuberculous mycobacteria in the U.S. (Cassidy et al., 2009). Historically, men
comprised a majority of those who were infected with NTM, however, the majority of NTM
infected individuals are currently women (Cassidy et al., 2009; Falkinham, 2016; Griffith, 2017).
Pulmonary NTM disease has shown increased incidence and mortality rates with increasing age in
both males and females (Henkle et al., 2015; Mirsaeidi et al., 2014). Without population-based
data, the burden of disease due to different NTM species is currently unknown, but the most
commonly identified NTM species causing disease in humans in the U.S. are the species of the M.
avium complex (MAC) and M. kansasii (Griffith et al., 2007; Griffith, 2017; Prevots & Marras, 2015).
Other medically important species include M. chimaera, M. abscessus, M. chelonae, and M.
fortuitum (Falkinham, 2016).
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As the prevalence of NTM disease has appeared to increase with no obvious environmental
source, experts believe that host factors are of increasing importance in the pathogenesis of NTM
infections. Host factors have also been thought to be related to the severity of the disease
experienced (Mirsaeidi et al., 2014). Two major categories of NTM disease are pulmonary and
nonpulmonary. There are a few groups of individuals that have been found to be at a particularly
heightened risk for pulmonary NTM disease (Falkinham, 2016; Griffith, 2017). The first high-risk
group includes older men who are smokers and heavy alcohol drinkers. This group is at increased
risk of developing NTM pulmonary infection (Falkinham, 2016; Griffith, 2017). The second group
also involves older men who suffer extensive lung damage from occupational exposures to dusts.
These individuals can include, but are not limited to, miners and farmers (Falkinham, 2016). A third
population group with higher risk of NTM pulmonary disease are thin (BMI < 20), older women
above the age of 50 years (Falkinham, 2016; Griffith, 2017; Prevots & Marras, 2015). These women
are generally nonsmokers with no underlying lung disease (Griffith, 2017). Immunodeficiency has
been found to be a risk factor of nonpulmonary disease, most often resulting in disseminated
disease (Falkinham, 2016; Griffith, 2017). Comorbidities are commonly found in patients with
pulmonary nontuberculous mycobacteria disease. Among these comorbidities include Human
Immunodeficiency Virus (HIV), Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis, and
cystic fibrosis (Mirsaeidi et al., 2014; Prevots et al., 2010).
Nonpulmonary NTM infections often occur in normally sterile body sites and are a cause of
both sporadic and healthcare associated infections (Bancroft et al., 2017). Nonpulmonary NTM
infections typically present clinically as superficial lymphadenitis, disseminated disease, and skin
and soft tissue infections (Bancroft et al., 2017; Griffith, 2017). Cases of superficial lymphadenitis
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primarily occur in children (ages 1 to 5 years) and most often present as cervical lymphadenitis
(Piersimoni & Scarparo, 2009). These cases are most frequently caused by M. avium complex and
M. scrofulaceum in the U.S. (Bancroft et al., 2017; Griffith 2017; Piersimoni & Scarparo, 2009).
Patients impacted by lymphadenitis are generally otherwise healthy and clinically present with a
chronic neck mass (Piersimoni & Scarparo, 2009). Disseminated disease primarily affects severely
immunocompromised patients and is believed to arise from infection of a mucosal surface and
subsequent local multiplication and entry into the bloodstream (Bancroft et al., 2017; Griffith
2017). Cases of NTM impacting the musculoskeletal system are rare, however, they do occur from
both rapidly and slow growing species in the bones and joints (Piersimoni & Scarparo, 2009). Lastly,
skin and soft tissue infection can also occur, most often as a result of direct inoculation (Griffith,
2017). Cutaneous NTM infections have also been found in immunocompromised patients, as well
as in immunocompetent persons resulting from a traumatic injury, surgery, or cosmetic procedures
(Piersimoni & Scarparo, 2009; Wentworth, Wengenack, Wilson, & Lohse, 2013).
Healthcare Associated Infections
There is evidence of healthcare associated NTM infections involving hematopoietic stem
cell transplant recipients, cardiac surgery, dialysis, injections, plastic surgery, liposuction, LASIK,
long-term central intravenous catheters, and a variety of surgical procedures (Baker et al., 2017;
Bancroft et al., 2017; Griffith et al., 2007; Li et al., 2017). Previously documented sources of NTM in
healthcare settings include tap water, ice made from tap water, distilled water used for preparing
solutions, and processed tap water used for dialysis (Griffith et al., 2007). From a systematic review
of NTM infections from healthcare facility water systems, Li et al. found that the median attack rate
of patients infected per patients exposed to NTM in health care settings was 12.1% and that the
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most affected populations include the immunocompromised, post-surgical and hemodialysis
patients (Li et al., 2017).
Recently, a notable outbreak of nonpulmonary invasive NTM infection occurred among
hospital patients who underwent cardiopulmonary bypass during cardiac surgery. This was
hypothesized to be due to aerosols generated from colonized heater-cooler units (Baker et al.,
2017). The primary organism responsible for NTM contamination in heater-cooler devices is the
slow-growing M. chimaera (Ninh, Weiner, & Goldberg, 2017). Positive M. chimaera cultures have
been drawn from a range of specimen sources including cardiac tissue, bone, blood, cardiac
prostheses, and urine (Ninh et al., 2017). Individuals in hospital settings are a vulnerable population
and if exposed to NTM, are more likely to become ill than the general population (Li et al., 2017). A
majority of exposed patients are initially asymptomatic, although, when symptoms are present,
patients often exhibit cardiac complications that can be fatal (Ninh et al., 2017). A median of 21
months from the time of cardiac surgery to the onset of symptoms has been described, however,
latency periods have been reported anywhere from three months to five years (Ninh et al., 2017;
Sommerstein et al., 2017). With a limited number of reported cases, the impact of M. chimaera has
not yet been thoroughly measured and accordingly, a specific treatment course has not been
defined (Ninh et al., 2017; Sommerstein et al., 2017). The American Thoracic Society/Infectious
Diseases Society of America (ATS/IDSA) guidelines recommend that surgical wounds, injection sites,
and intravenous catheters are not exposed to tap water to tap water-derived fluids to prevent
healthcare related NTM infections (Griffith et al., 2007).
Another outbreak, this time of M. abscessus occurred in association with a pediatric dental
clinic (Hatzenbuehler et al., 2017). Facial and neck swelling occurred among 24 children who
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underwent a pulpotomy where municipal water was used for the drilling and irrigation
(Hatzenbuehler et al., 2017). Among 24 children, the median age was 7.3 years and clinical
diagnoses included cervical lymphadenitis, mandibular or maxillary osteomyelitis, and disseminated
infection with pulmonary nodules (Hatzenbuehler et al., 2017). All of the children were hospitalized
at least once and there was a median of two surgeries per child (Hatzenbuehler et al., 2017). 79%
of the children experienced complications including vascular access malfunction, high-frequency
hearing loss, permanent tooth loss, facial nerve palsy, urticarial rash, elevated liver enzyme levels
acute kidney injury, neutropenia, and incision dehiscence/fibrosis (Hatzenbuehler et al., 2017).
Outbreaks of extrapulmonary NTM infection have also occurred in patients undergoing
dialysis (Phillips & Von Reyn, 2001). Typically caused by contaminated water solutions or the use of
colonized potable water in the processing of reusable hemodialysis filters, M. fortuitum infection
has caused clusters of peritonitis cases in individuals on continuous ambulatory peritoneal dialysis
(Phillips & Von Reyn, 2001). M. chelonae and M. abcessus have also been associated with
outbreaks among patients undergoing dialysis (Phillips & Von Reyn, 2001).
Diagnosis of NTM
When diagnosing nontuberculous lung disease, microbiologic, clinical, and radiographic
criteria are all equally important. According to the ATS/IDSA, to meet the criteria for the diagnosis
of NTM lung disease, the minimum evaluation of a patient must include “chest radiograph or, in
the absence of cavitation, chest high-resolution computed tomography (HRCT) scan; three or more
sputum specimens for acid-fast bacilli (AFB) analysis; and exclusion of other disorders, such as
tuberculosis” (Griffith et al., 2007, p. 367). These 2007 ATS/IDSA guidelines are in agreement with
the British Thoracic Society Guidelines published in 2017 (Haworth et al., 2017). Many studies rely
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on microbiologic evidence alone to identify NTM lung disease, with the ATS/IDSA defining
microbiologic evidence of pulmonary disease as positive culture results from at least two separate
sputum samples, positive culture results from one or more bronchial wash or lavage, or
transbronchial or other lung biopsy with mycobacterial histopathologic features in addition to a
positive culture for NTM or biopsy showing mycobacterial histopathologic features and a positive
culture from one or more sputum or bronchial washings (Griffith et al., 2007).
The diagnosis of extrapulmonary disease varies based on clinical manifestation and species
identified (Griffith et al., 2007). Guidelines for nonpulmonary NTM case ascertainment have
recently been established by the Council of State and Territorial Epidemiologists (CSTE). Suggested
laboratory criteria for a confirmatory case of nonpulmonary NTM are as follows: “a positive culture
and identification to the species or complex level of nontuberculous mycobacteria, or positive
nucleic acid test specific for a given species or complex of nontuberculous mycobacteria” excluding
specimens that indicate M. tuberculosis complex organisms, M. gordonae, or M. leprae, and
excluding cultures from lower respiratory samples (Bancroft et al., 2017, p. 5). Guidelines for
treatment vary based on the species identified and the severity of disease, but typically consists of
3 to 6 months of multi-drug antimicrobial therapy (Griffith et al., 2007; Haworth et al., 2017;
Henkle, Hedberg, Schafer, & Winthrop, 2017). An effective treatment regimen has not been
identified for some species and disease combinations such as treatment of M. abscessus pulmonary
disease (Griffith et al., 2007). Guidelines for susceptibility testing also vary by species identified and
should only be carried out when there is clinical suspicion of disease (Griffith et al., 2007; Haworth
et al., 2017). Although the antimicrobial susceptibility varies, high rates of resistance have been
seen for some species (Florita, Zangeneh, & Georgescu, 2017).
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Project Significance
The public health and economic burdens of NTM disease in the U.S. are unknown, however,
there are estimates of the disease burden and the costs associated with it. Strollo et al. estimated
that there were 86,244 cases of NTM disease in the U.S. in 2010, equating to about $815 million in
costs (Strollo, Adjemian, J., Adjemian, M., & Prevots, 2015). The state estimates came out to a
median of 1,208 annual cases with an estimated range of 48 to 12,544 cases per year in each state.
This associated cost ranges from $503,000 to $111 million per year in each U.S. state (Strollo et al.,
2015).
Further research is needed to quantify the complete burden of disease on public health, to
identify the risk factors associated with NTM disease, to estimate the cost of NTM disease, and to
further inform public health interventions (Cassidy et al., 2009; Henkle et al., 2015; Prevots &
Marras, 2015; Strollo et al., 2015). And while reporting of nontuberculous mycobacterial infection
is not mandated for the United States as a whole, it is mandated in the state of Nebraska. Using
reports of NTM infection in the state of Nebraska from 2012 until 2017, the objectives of this
project were to estimate the population-based prevalence of NTM disease in Nebraska and to
describe the patterns of NTM infection including location, species, specimen source, and patient
demographic characteristics. This project serves to better estimate the burden of NTM in the
United States through population-based prevalence and the associated risk factors of NTM
infection within the state of Nebraska. By understanding the scope of the disease, populations
affected, and species involved, public health professionals and health care providers can better
understand the need for additional surveillance and which populations are at risk of NTM infection,
in order to improve surveillance methods and develop strategies for prevention.
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This project was conducted in collaboration with the Nebraska Department of Health and
Human Services (DHHS) whose mission serves to help people live better lives (Nebraska
Department of Health and Human Services [DHHS], 2017). At every level of DHHS, their goal is to be
honest, trustworthy, competent and loyal. DHHS strives to be transparent and accountable as they
protect the health of and serve the residents of Nebraska (DHHS, 2017). Within the Epidemiology
Department, I worked with the Healthcare Associated Infections (HAI) group.
Methods
Study design & data collection. A retrospective review of surveillance reports of nontuberculous
mycobacteria was conducted to provide estimates of the burden of infection in Nebraska.
Nontuberculous mycobacteria (NTM) infections have been reportable in the state of Nebraska
beginning in 2010, but this reporting was not considered reliable until 2012 due to the time
required to establish this reporting with providers and laboratories. Nebraska was one of the first
states to adopt the Center for Disease Control and Prevention’s electronic platform for disease
reporting. The system is called the Nebraska Electronic Disease Surveillance System (NEDSS) in
Nebraska, and there are an additional 23 jurisdictions that utilize this platform to extract relevant
information from the HL7 messages that are sent via Public Health Information Network (PHIN)
secure messages to the NEDSS system (CDC, 2017). NEDSS was searched for all NTM infections
reported from 01/01/2012 to 12/31/2017 to examine the burden of NTM infections in the state of
Nebraska over this six-year period. All of the data that was used for analysis was extracted from the
NEDSS database into Microsoft Excel and cleaned using SAS Software version 9.4 (SAS Institute,
Inc., Cary, North Carolina). The University of Nebraska Medical Center Institutional Review Board
approved of this investigation.
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Variables. Patient state and/or local health department jurisdiction were used to determine
residency in the state of Nebraska. The date the isolation was first reported was used to determine
the year reported and was used in annual rate calculations.
Specimen source. To identify the specimen source from which the sample was collected, all of the
information from four available specimen source fields was examined and manually reviewed for
each of the individual reports. The specimen source was then classified by body site or source of
the specimen depending on the data available. Specimen source was primarily defined by the body
site it was obtained from as it provided more information pertaining to pulmonary and
nonpulmonary cases. If information conveying the body site was not available, specimen source
was defined by the type of source it was from (i.e. body fluid, aspirate, tissue, abscess, etc.). The
specimen sources were then categorized into pulmonary and nonpulmonary based on medical
expertise and current literature. All specimen source categorizations were verified by Nebraska
DHHS supervisors. If no information was provided in any of the fields for specimen source, it was
designated as missing. Information on specimen source was not available for nearly half of the
samples, therefore the American Thoracic Society/Infectious Diseases Society of America definition
of clinical disease could not be applied. Additionally, none of the patients had more than one
report and so ATS/IDSA recommendations of at least 2 consecutive sputum samples could not be
applied. Therefore, the sample that was analyzed here represents only reports of positive isolates
and not confirmed clinical cases since the necessary supporting information was not reported to
public health. Specimens from environmental sources that were not connected to an individual
were noted and subsequently removed before analysis.

12

Pulmonary NTM. Isolation of pulmonary NTM was defined as one positive laboratory test from
sputum, bronchial wash, lavage or culture, specimens from the chest wall, sinus or pleural fluid, or
lung tissue or biopsy.
Nonpulmonary NTM. Nonpulmonary NTM was categorized into skin/soft tissue, bone/joint,
disseminated, lymphadenitis, and other. A case of skin/soft tissue was defined as specimens from
wounds, mass, lesions, muscle, or bodily tissue. Isolates from tissue or drainage from bone or joints
were defined as bone/joint. A disseminated case was defined as isolation from cerebrospinal fluid,
blood, or heart. Lymphadenitis is defined as isolation from lymph node tissue or aspirate. The
category of other includes all other nonpulmonary isolates including those from swabs, glands,
urine, stool, peritoneal fluid, abdominal fluid, other unidentified body fluid, eye, ear, and neck.
Mycobacterium Gordonae isolates were considered as contaminates and excluded from analysis.
Device. Specimens identified as isolated from a catheter tip were defined as a device, and
categorized as neither pulmonary nor nonpulmonary isolation.
Species type. Species type was derived from two fields indicating the test performed and the result
from that test. As this data was inconsistently entered, a new variable for species type was created.
A manual review of the two fields was conducted and the identified species was input into the new
field using Microsoft Excel. All results, including species identified as “Group IV Rapid Growers”,
that did not specify a species type were assigned as missing.
Age. Age in years was computed by subtracting the patient’s date of birth from the specimen
collection date.
Exclusion Criteria. Laboratory reports from individuals who reside outside of the state of Nebraska,
those from an environmental source that is not connected to an individual, and those reported
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before January 1st, 2012 or after December 31st, 2017 were excluded. Negative laboratory reports,
or those for tests other than nontuberculous mycobacteria were also excluded.
Data Analysis. Laboratory data was imported and managed using SAS Software version 9.4 (SAS
Institute, Inc., Cary, North Carolina). Frequencies, percentages, means, standard deviations, were
computed using SAS Software version 9.4. Isolation rates were computed using Microsoft Excel.
Population estimates used in rates were determined using the U.S. Census Bureau’s annual
population projections (U.S. Census Bureau, 2017).
Data quality: An examination of data quality was conducted in order to recommend improvements
for future surveillance. Data quality was assessed through the identification of missing data and the
evaluation of the timeliness and consistency of reporting. Timeliness of reporting was assessed
through a measure of the time from sample collection to case reporting. This was computed by
subtracting the laboratory report date from the specimen collection date reported and measured
in days. An examination of outliers in the data was conducted to identify possible data misentry.
Laboratory reports identified as test reports from varying facilities were removed before analysis. A
qualitative examination of the consistency of reporting was conducted by comparing consistency of
data entry throughout reports from different reporting facilities and ordering organizations.
Results
During 2012 to 2017, there were 759 reports of nontuberculous mycobacteria in the state
of Nebraska for a period isolation rate equal to 40.21 cases per 100,000 population over the 6-year
period. The annualized isolation rate was 6.70 cases per 100,000 population and 6.16 cases per
100,000 population after exclusion of Mycobacterium Gordonae. From the original 934 lab reports
from this time period, 111 were excluded due to residency outside of Nebraska or an unknown
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location, 57 were excluded due to negative results or because results reported detected organisms
other than NTM including Mycobacterium Tuberculosis, Mycobacterium Leprae, Histoplasma
Capsulatum, and Corynebacterium Amycolatum, and 7 results from environmental sources were
excluded because they were not connected to an identifiable patient (Figure 1). Environmental
sources reported include scrub sink aerators, PMS water, turnout tap PMS, and counter tap H 2O
PMS. Species identified from environmental sources include Mycobacterium Mucogenicum,
Mycobacterium Avium Intracellulare, Mycobacterium Chimaera, Mycobacterium Kansasii, and
Mycbacterium Arupense.
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Figure 1. Sample Flow Diagram

All lab reports in NTM datamart
from 2012-2017
N=934

NTM lab reports from Nebraska
residents
N=823

NTM lab reports with a positive
test result
N=766

111 excluded due to residency
otuside of Nebraska, or missing
location data

57 excluded due to negative test
results, identification as a test
report, or due to result from other
test besides NTM

7 results from environmental
sources excluded due to no
identifiable patient
Nonpulmonary Samples
N= 209

Final Sample Size
N=759

Pulmonary Samples
N=180

Specimen Source Missing
N= 368
Specimen Source from Device (N=2)

Data quality. 388 reports had complete data for patient age, patient gender, specimen source,
species type, specimen collection date, and lab report date. Missing data were observed for
specimen source, gender, species type, ordering organization, and patient address. Information
regarding the specimen source was missing for nearly half of the cases (46.42%). The quality of this
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measure improved over time with a large decrease in missing data for specimen source from 68%
of cases in 2012 to 15% of cases in 2017 missing data for specimen source. Nearly half (46.47%) of
the cases were also missing the patient’s address. Less than 5% of cases did not identify a species
type isolated (n=32, including 6 cases with the species reported as Group IV Rapid Grower) and less
than 1% of cases were missing information for the patient’s gender (n=5). 3.29% of the ordering
organizations were missing (n=25). 10 test laboratory reports all from the same reporting facility
were identified and therefore excluded. 47 reports were excluded due to negative results or due to
results identifying organisms other than NTM. Over the 6-year period 14 different facilities
reported at least one NTM isolate.
Ages ranged from 0 to 97 years with a mean of 57 years (STD=22.57 years). The mean age
for patients with pulmonary isolates was nearly twenty years older than the mean age of patients
with nonpulmonary isolates. A majority of the overall sample were males (53%). The time from
sample collection to laboratory reporting ranged from 0 to 393 days with an overall mean of 35.5
days. This overall mean greatly differs from that of reports with complete data for the specimen
source as seen in Table 1a.
Of the cases with an identified specimen source, 180 (46%) were pulmonary and 209 (54%)
were nonpulmonary cases. The specimen source from 368 cases was not identified. It should also
be noted that the specimen source for two cases was documented as being obtained from a device
and therefore was not categorized into either pulmonary and nonpulmonary. The species identified
in both cases was Mycobacterium Mucogenicum, and both were from a catheter tip. They do not
appear to be connected as they are from different facilities during different time periods.
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Table 1a. Characteristics of Individuals With Positive Lab Reports of Nontuberculous Mycobacteria
By Specimen Source, Nebraska, 2012-2017 (n=388)
Specimen Sourcea,b
NonPulmonary (n=208)

Pulmonary (n =180)

No.

%

No.

%

105
103

50.48
49.52

102
78

56.67
43.33

9

4.33

53

29.44

2013

9

4.33

79

43.89

2014

31

14.90

10

5.56

2015

44

21.15

20

11.11

2016

62

29.81

7

3.89

2017

53

25.48

11

6.11

Sexc
Male
Female
Specimen Collection Year
2012

Age, yearsd

46.98 (26.16)

65.50 (18.23)

Time from Sample Collection to Lab
Report, daysd

25.68 (20.94)

25.14 (24.28)

a 368 observations with missing specimen data were excluded from descriptive statistics
b 2 observations with device as the specimen source were excluded from descriptive statistics
c 1 observation with missing gender was excluded from descriptive statistics
d values expressed as mean (standard deviation)

24 species types including the contaminant, Mycobacterium Gordonae, and Mycobacterium
Chimaera, from an environmental source, were identified (Table 1b). A majority of isolates (58%)
were identified as Mycobacterium Avium Intracellulare with an annualized isolation rate of 3.71
cases per 100,000 population. The second most commonly isolated species was Mycobacterium
Chelonae with an annualized isolation rate of 0.81 cases per 100,000 population.

Table 1b. Reported Isolates by Species Type, Nebraska NTM Infections 2012-2017 (n=727a)
Speciesb,c,d
M. Abscessus
M. Arupense
M. Aurum
M. Avium Intracellulare

No. (%) of reported isolatesb
33 (4.54)
12 (1.65)
1 (0.14)
420 (57.77)

Annualized Isolation Rateb,f
0.29
0.11
…
3.71
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M. Chelonae
M. Chelonae/Abscessus Complex e
M. Fortuitum
M. Goodii

92 (12.65)
1 (0.14)
41 (5.64)
1 (0.14)

0.81
…
0.35
…

M. Gordonaeg

61 (8.39)

…

M. Immunogenium

1 (0.14)

…

M. Kansasii

15 (2.06)

0.13

M. Lentiflavum

1 (0.14)

…

M. Mageritense

1 (0.14)

…

M. Marinum

6 (0.83)

0.05

M. Massilense

1 (0.14)

…

M. Monacense

1 (0.14)

…

M. Mucogenicum

28 (3.85)

0.25

M. Neoaurum

3 (0.41)

0.03

M. Peregrinum

2 (0.28)

0.02

M. Phocaicum

1 (0.14)

…

M. Scrofulaceum

1 (0.14)

…

M. Smegmatis

1 (0.14)

…

M. Terrae

3 (0.41)

0.03

a 28 observations with missing species data were excluded
b Isolates from environmental sources are not included
c Mycobacterium Chimaera is excluded due to isolation from an environmental source
d 4 species identified as Group IV Rapid Grower were excluded
e Results from a former reporting system unable to differentiate between M. Chelonae and M. Abscessus
f Rates ≤0.01 were excluded
g Considered a contaminant so rate was not calculated

The overall rate of isolation, excluding Mycobacterium Gordonae, decreased throughout the
study period from 9.33 isolates per 100,000 persons in 2012 down to 3.75 isolates per 100,000
persons in 2017 (Figure 2). The isolation trends differed for pulmonary and nonpulmonary isolates
(Figures 3a & 3b). Although the overall rate of isolation decreased throughout the 6-year period,
however, the rate of isolation in nonpulmonary cases increased from 0.48 to 2.60 isolates per
100,000 persons after exclusion of Mycobacterium Gordonae. This is contrary to the decrease in
pulmonary cases from 2.32 to 0.57 isolates per 100,000 persons after exclusion of Mycobacterium
Gordonae.
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Figure 2. Annual NTM Isolation Rate per 100,000 population in Nebraska from 2012 to 2017a,b
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a Isolates identified as M. Gordonae were excluded due to identification of M. Gordonae as a contaminant
b Population estimates used in rates were determined using the U.S. Census Bureau’s annual population projections

Figure 3a. Annual Nonpulmonary NTM Isolation Rate per 100,000 population in Nebraskaa,b
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a Isolates identified as M. Gordonae were excluded) due to identification of M. Gordonae as a contaminant
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b Population estimates used in rates were determined using the U.S. Census Bureau’s annual population projections

Figure 3b. Annual Pulmonary NTM Isolation Rate per 100,000 population in Nebraskaa,b
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a Isolates identified as M. Gordonae were excluded due to identification of M. Gordonae as a contaminant
b Population estimates used in rates were determined using the U.S. Census Bureau’s annual population projections

The species identified from a majority of the nonpulmonary isolates, and within each
category, was Mycobacterium Avium Intracellulare (Table 2). All of the isolates categorized as
lymphadenitis (n=5) were identified as Mycobacterium Avium Intracellulare. The most frequently
isolated specimens were from skin/soft tissue (31.5%), followed by isolates from bone/joints (19%).
Table 2. Species Distribution Characterized by Nonpulmonary Specimen Source, Nebraska NTM
Infections 2012-2017a (n=200)
Bone/Joint
(n=38)

Nonpulmonary Specimen Source
Disseminatedc
Lymphadenitisd
Skin/Soft
(n=20)
(n=5)
Tissuee (n=63)

Otherf (n=74)

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

2 (5.26%)

2 (10.0%)

0

4 (6.35%)

5 (6.76%)

M. Avium Intracellulare

18 (47.37%)

10 (50.0%)

5 (100%)

30 (47.62%)

49 (66.22%)

M. Chelonae

11 (28.95%)

0

0

8 (12.70%)

7 (9.46%)

Species Typea,b
M. Abscessus
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M. Chelonae/Abscessus
Complex g

0

1 (5.0%)

0

0

0

3 (7.89%)

3 (15.0%)

0

6 (9.52%)

2 (2.70%)

0

0

0

0

1 (1.35%)

M. Gordonae

2 (5.26%)

0

0

5 (7.94%)

6 (8.11%)

M. Mageritense

1 (2.63%)

0

0

0

0

M. Massiliense

0

0

0

0

1 (1.35%)

M. Marinum

0

0

0

3 (4.76%)

1 (1.35%)

M. Monacense

0

0

0

1 (1.59%)

0

1 (2.63%)

3 (15.0%)

0

5 (7.94%)

2 (2.70%)

M. Neoaurum

0

1 (5.0%)

0

0

0

M. Smegmatis

0

0

0

1 (1.59%)

0

M. Fortuitum
M. Goodii

M. Mucogenicum

a 7 observations with missing species data were excluded
b 2 species identified as Group IV Rapid Grower were excluded
c Blood, cerebrospinal fluid, & heart included in ‘Disseminated’
d Lymph node included in ‘Lymphadenitis’
e Wound, mass, abscess, & lesion included in ‘Skin/Soft Tissue’
f Urine, stool, peritoneal fluid, neck, ear, eye, body fluid, aspirate, biopsy, gland, swab, & abdominal fluid/abdomen included in ‘Other’
g Results from a former reporting system unable to differentiate between M. Chelonae and M. Abscessus

Discussion
A population-based assessment of patients with both pulmonary and nonpulmonary NTM
isolates reported in the state of Nebraska was conducted over a six-year period from 2012 to 2017.
This assessment estimates an existing annualized population-based isolation rate of NTM in
Nebraska of 6.16 cases per 100,000 population (excluding Mycobacterium Gordonae). However, in
contrast with other documented North American studies reporting an increase in NTM isolation
and disease, there was an observed overall decrease in rates of NTM isolation in Nebraska from
9.33 isolates in 2012 to 3.75 isolates per 100,000 population in 2017 (Adjemian et al., 2017; Brode
et al., 2017; Henkle et al., 2015). While rates of pulmonary NTM isolation and disease have been
cited as increasing in other studies, estimated rates of pulmonary NTM isolation in Nebraska
decreased from 2.32 isolates in 2012 to 0.57 isolates per 100,000 population in 2017 (Adjemian et
al., 2017; Henkle et al., 2015). Conversely, rates of nonpulmonary NTM isolation had an overall
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increase during this study period from 0.48 isolates in 2012 to 2.6 isolates per 100,000 population
in 2017. Similar to other U.S. studies, the majority of cases were due to Mycobacterium Avium
(Adjemian et al., 2017; Cassidy et al., 2009; Henkle et al., 2015; Smith et al., 2016; Winthrop et al.,
2010). Recent studies have found a predominance of female cases, however, the majority of
Nebraska cases were male.
A similar evaluation in Ontario, Canada by Brode and colleagues found an increase in NTM
isolation rates from 11.4 isolates per 100,000 population in 1998 to 22.2 NTM isolates per 100,000
population in 2010. This equated to a prevalence of NTM disease of 4.65 cases per 100,000
population in 1998 which increased to 9.08 cases per 100,000 population in 2010. The annual
prevalence of pulmonary cases was found to steadily increase, while the annual prevalence of
nonpulmonary cases did not change substantially over time (Brode et al., 2017). Population-based
studies of NTM disease have also been conducted in Oregon. Contrary to our findings, Henkle and
colleagues estimated the incidence of pulmonary NTM disease in Oregon increased from 4.8 cases
per 100,000 population in 2007 to 5.6 cases per 100,000 population in 2012 and that the annual
incidence of extrapulmonary NTM disease was stable from 2007 to 2012 averaging at 1.5 cases per
100,000 population (Henkle et al., 2015; Henkle et al., 2017). Other North American studies have
also found a predominance of pulmonary cases contrasting to the majority of nonpulmonary cases
(54%) in Nebraska. A study of three counties in North Carolina from 2006 to 2010 found a
predominance of pulmonary NTM isolations (79.4% of all isolates with an identified source)
compared to nonpulmonary isolates (20.6%) (Smith et al., 2016). A majority of cases in Oregon
from 2005 to 2006 (77.2%) and Onatrio, Canada from 1998 to 2010 (96%) were also pulmonary
(Brode et al., 2017; Cassidy et al., 2009). The difference in rates of pulmonary isolates in Nebraska

23

as compared to in other regions may be indicative of a decrease in either testing or reporting of
pulmonary NTM disease in Nebraska.
Over a six-year period from 2007 to 2012, Henkle et al. found 334 nonpulmonary NTM
isolates in the state of Oregon compared to 200 nonpulmonary NTM isolates found in Nebraska
over the six-year period from 2012 to 2017. In Oregon, a majority of these isolates were identified
as skin/soft tissue (58.9%). Comparably, nonpulmonary infections in Nebraska classified as ‘other’
predominated (37%), followed by skin/soft tissue infections (31.5%). In Nebraska, infections of the
bones or joints made up 19% of nonpulmonary infections while infections of the joints made up
only 4% of nonpulmonary infections in Oregon (Henkle et al., 2017). These differences may result
from differences in the categorization of infections, true differences in infections, and the
differences in the reporting time period. Because infection site classifications vary between studies,
it is difficult to directly compare results by site. However, it is notable that at least one NTM
infection of the eye was reported in both Oregon and Nebraska (Henkle et al., 2017).
Over a thirteen-year period (1998 – 2010) there was an average of 103 annual isolates of
nonpulmonary NTM reported in Ontario, Canada making up 4% of all NTM isolates (Brode et al.,
2017). Gastrointestinal system/genitourinary system infections (included in the ‘other’ category in
our analysis) made up 40% of these infections, followed by skin and soft tissue (22%) and
blood/bone marrow (22%) infections. Only 6% of nonpulmonary infections were of the
musculoskeletal system and 3% of the lymph nodes (Brode et al., 2017). This is comparable to
Nebraska in which only 3% of nonplumonary infections were of the lymph nodes.
A study of medical records from Banner University Medical Center in Tucson, Arizona
identified 33 nonpulmonary NTM isolates in patients older than 18 years from 2012 to 2016 in
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which 27% were skin and soft tissue, 27% were bone and joint, and 15% were from stool. One case
was also identified in brain tissue (Florita et al., 2017). Skin and soft tissue and gastrointestinal
system/genitourinary system infections have been found to make up a significant amount of
nonpulmonary NTM infections in North America, however, there have been reports of infections in
other notable places including the heart (Nebraska), eye (Nebraska & Oregon), and brain tissue
(Tucson, Arizona) (Florita et al., 2017; Henkle et al., 2017).
This evaluation is the first of its kind to estimate both pulmonary and nonpulmonary
isolation rates in the state of Nebraska. A strength of this study is that it provides true populationbased estimates due to the mandatory reporting of NTM infections in the state of Nebraska. Few
other U.S. states mandate the reporting of NTM infection and therefore rely on collaborations with
individual laboratories for disease estimation.
A notable limitation is the inability to accurately estimate specific clinical manifestations
and measures of NTM disease due to the large quantity of cases missing information regarding the
specimen source (46%). Additionally, in many cases, pulmonary disease was not able to be
established according to the ATS/IDSA guidelines for sputum samples (2+ positive cultures from
consecutive samples) because no patient had more than one report within the six-year period.
Consequently, isolation rates were computed to provide a better capture of the burden of NTM in
Nebraska, as disease estimates from the current data would greatly underestimate that burden in
Nebraska.
Winthrop et al. found that the microbiologic criteria alone was highly predictive of
pulmonary disease with 86% of patients meeting the ATS/ISDA microbiologic criteria also meeting
the full ATS/IDSA disease criteria (Winthrop et al., 2010). Other studies have successfully used the
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guidelines for 2+ consecutive positive sputum samples to determine pulmonary NTM disease rates,
however, further research should examine typical practices for and timeliness of retesting
individuals with positive sputum samples to determine if this definition of disease is practical
(Brode et al., 2017; Cassidy et al., 2009; Henkle et al., 2015; Winthrop et al., 2010).
Additional limitations include a likely underestimation of the isolation rates due to the
indolent nature of NTM disease, the possibility of some laboratories failing to report cases of NTM
infection to DHHS, and underreporting of Nebraska residents who seek care in bordering states
that are not included in the sample.
Less than 5% of cases were missing information regarding the species type isolated,
however, the implementation of a requirement for the reporting of species type identified in all
laboratory reports is recommended. It is recommended by the ATS/IDSA that species-level
identification be established due to differences in antimicrobial susceptibility that determine
treatment options (Griffith et al., 2007). The species type contains valuable information for the
identification of outbreaks as well as for antimicrobial susceptibility.
Along with this, it is recommended that laboratories be encouraged to submit complete
reports which should include specimen source. The specimen source is required to establish
disease and it is suggested that pulmonary and nonpulmonary NTM represent different diseases
with different risk factors (Brode et al., 2017). Therefore, information regarding the specimen
source is required not only to estimate the burden of disease, but also, to identify outbreaks and
risk factors. Although there is a place for clinical information in the laboratory reporting, it was
missing for 100% of the sample. When tracking possible healthcare associated outbreaks,
correlation of positive cultures with clinical symptoms is imperative to avoid pseudo-outbreaks and
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unnecessary treatment. Contamination of samples is common and positive samples tend to be
more likely to indicate contamination than disease (Li. et al, 2017). It is therefore also
recommended that methods to obtain this kind of information with laboratory reports should be
considered.
Conclusion
This assessment provides the first population-based estimates of both pulmonary and
nonpulmonary NTM isolation rates in the state of Nebraska. Contrary to other studies, there was
an overall decrease in NTM isolation over the study period from 2012 to 2017, however, there was
an increase in nonpulmonary NTM isolates. These results, along with findings from other studies,
may suggest that the difference in trends for pulmonary and nonpulmonary NTM isolates indicate a
difference in disease and different associated risk factors. This may also be indicative of a decrease
in reporting or testing of pulmonary isolates in Nebraska. Recommendations include improvements
to the NTM surveillance system in Nebraska to produce higher quality data for future disease
estimation and outbreak identification. Further evaluation should be conducted to monitor disease
trends and risk factors to inform public health management of infections with these organisms.
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Service Learning/Capstone Experience Reflection
The Nebraska Department of Health and Human Services was the placement site for my
service learning and capstone experience. Before this project, I had never been to the state health
department, and didn’t know much about how it functioned. It was a good experience for me to
learn about the organizational structure and how it differed from local health departments.
Nebraska DHHS is uniquely placed because it is not only a health department, but it also provides
social services, which is not true of all state health departments. My preceptor, Dr. Pedati, did a
good job of introducing me to the organizational structure of DHHS when I first started my project
there. I did not expect approval to be needed from so many levels of leadership to complete
various tasks and achieve goals. I learned about the importance of this in ensuring that everyone in
the health department is on the same page and working together to achieve similar goals.
I learned how DHHS collaborates with local health departments, as well as nationally with
the Centers for Disease Control and Prevention. Dr. Pedati and Dr. Tierney are members of the
Council of State and Territorial’s healthcare associated infections subgroup, and they invited me to
listen in on a couple of the monthly calls. I enjoyed learning about how health departments and
epidemiology professionals from across the country collaborate together and communicate about
what is going on in their health departments and areas for improvement.
Other service learning activities included participation in the healthcare associated
infections (HAI) group at Nebraska DHHS. I attended weekly meetings where I learned about the
projects that everyone was working on, as well as updated them on my progress assessing the
atypical mycobacteria data. While working with the HAI group, I assisted with various projects as
needed including conducting research on various topics regarding healthcare associated infections.
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I also helped with the preparation of events such as Antibiotic awareness week. November 13-19 is
US Antibiotic Awareness Week, so I worked with the HAI group for the promotion of Antibiotic
Awareness Week in Nebraska. Dr. Tierney headed an effort for the official proclamation of
Antibiotic Awareness Week in Nebraska by Gov. Pete Ricketts and I worked with the rest of the HAI
group in the set up and promotion of Antibiotic Awareness Week. We set up a display in the state
capitol and answered questions about Antibiotic Awareness Week from visitors viewing our
display.
A large majority of my service learning involved data clean up. Before beginning my project,
I did not realize how large of an investment of time was needed for proper data clean up. My
project involved the assessment of a new surveillance system and required a large effort to clean
the data for analysis. My skills using SAS software aided me in my data clean up and allowed for me
to do it effectively. From this I also created a data dictionary describing the variables associated
with the NTM surveillance data for DHHS staff members to use in the future.
A major challenge I encountered during the data clean up portion of my service learning
was the messiness of the data. Most of the data I have worked with for class projects in the past
has been pretty structured and cleaned before I analyzed it. I did not anticipate how messy the
data was going to be, and therefore the time and effort it took to clean the data. An important
variable in the data set, specimen source, was very difficult to clean because it was located in four
different fields and was not systematically entered. Although I tried to use SAS to clean this field, I
could not find a way to do it without losing quality of the data. Ultimately, I manually went through
each of the observations to identify the correct specimen source. This became very useful in my
analysis as well as for DHHS. There was recently a healthcare associated case of NTM in which my
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data was needed to identify if any more cases had occurred. Because I had already spent time
cleaning the data, I was able to quickly send it to my preceptor for use in outbreak detection.
My service learning and capstone project have given me experience in applied epidemiology
and public health. From this experience I have learned that not everything is always as clean and
clear cut as it appears to be in school, and there often is not a clearly defined best way of doing
things. This has taught me to think critically and quickly on my feet to adapt to the various
situations I encountered. Although sometimes it was challenging, it ultimately made me excited to
dive into a career in epidemiology and public health.
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